U.S. Tobacco Stock News

Wondering if Innospec, at around its recent US$65.89 close, is offering value or a value trap? This review breaks down what the current share price really reflects. The stock has recently seen a 4% decline over the past week, an 18.9% decline over the past month, and a 29.9% decline over the last year, which may signal that the market is reassessing both growth potential and risk. Recent coverage of Innospec has focused on its position within the chemicals sector and how investors are...

TransUnion (NYSE:TRU) has rolled out new machine learning capabilities within its Device Risk fraud prevention solution. The update targets recent surges in digital fraud and suspected account takeovers, aiming to improve detection accuracy and reduce manual review work for clients. The company is highlighting adaptive, consortium driven risk scoring as a way to respond to more complex fraud patterns in digital channels. TransUnion enters this product update phase with its shares at $70.55...

In March 2026, AEye, Inc. announced it had joined the ANAB-accredited NVIDIA Halos AI Systems Inspection Lab to collaborate on validating safety, cybersecurity, and system integration of its Apollo, STRATOS, and OPTIS lidar solutions with NVIDIA DRIVE platforms. On the same day, AEye reported fourth-quarter 2025 sales of US$97,000 and a net loss of US$7.34 million, with full-year 2025 sales of US$233,000 and a net loss of US$33.96 million, showing modest revenue progress alongside continued...

If you are wondering whether FormFactor's current share price lines up with its underlying worth, this article will walk you through what the numbers are actually saying. The stock recently closed at US$92.22, with returns of 2.6% over 7 days, a 2.5% decline over 30 days, 55.8% year to date and 196.4% over 1 year that may catch your eye. Recent coverage has focused on FormFactor as a semiconductor testing specialist, with investors watching how its technology and customer exposure position...

TG Therapeutics, ticker NasdaqCM:TGTX, announced a new five year, $750 million senior secured credit facility with Blue Owl Capital. The agreement is described as non dilutive, meaning it does not involve issuing new equity to raise capital. The facility includes repayment of prior debt and could expand to as much as $1b in total available financing. TG Therapeutics focuses on developing and commercializing therapies in the biopharmaceutical space, where access to sizeable, flexible capital...

Investors may be wondering whether Progress Software's current share price reflects its true value, or if the recent weakness is opening up an opportunity. The stock closed at US$31.29, with returns of an 8.8% decline over 7 days, a 22.4% decline over 30 days, a 23.8% decline year to date, and a 42.5% decline over 1 year. These moves may have shifted how the market views its risk and reward trade off. Recent headlines have focused on Progress Software's role as a software provider and how...

If you are wondering whether Walker & Dunlop at around US$43.82 is starting to look like value, the recent share performance gives plenty to think about. The stock has seen a 2.6% decline over the past week, a 30.7% decline over the last month, and returns of 25.4% year to date and 46.7% over the past year, with a 33.2% and 51.6% decline over the last 3 and 5 years respectively. These moves have put valuation front and center for many investors who are reassessing what they are willing to...

If you are wondering whether RPC at US$6.83 is priced attractively or not, the starting point is understanding what the current market price might be implying about its future. Over the short term, the stock has returned 4.8% in the last 7 days, 12.0% over 30 days, 23.5% year to date, 28.6% over 1 year, and 38.1% over 5 years, while the 3 year return sits at a 4.0% decline. Recent coverage around RPC has focused on how investors are reassessing energy service providers, with attention on...

Jack Henry & Associates (NasdaqGS:JKHY) received the “Small Business Payments Solution of the Year” award at the FinTech Breakthrough Awards for its Tap2Local product. The recognition focuses on Tap2Local, a cloud-native payments solution designed for small business clients of banks and credit unions. For investors watching NasdaqGS:JKHY, this award offers insight into how the company is positioning itself within digital payments for community and regional financial institutions. Tap2Local...

Investors may be wondering whether CONMED's share price around US$35.94 reflects its true worth, or if the market has pushed it too far in one direction. The stock has seen weak recent returns, with a 3.6% decline over the last week, 20.4% over the last month, 11.3% year to date, and 39.3% over the past year. These moves can reshape how investors think about both risk and potential opportunity. Recent coverage has focused on CONMED as part of a broader look at medical equipment names, with...

To understand whether Waystar Holding at US$24.07 offers value or just looks cheap on the surface, you need to weigh the recent share performance against the fundamentals. Over the last week the stock returned 0.4% lower, over the last month it is 6.7% lower, and over the year it is 23.3% lower year to date and 35.8% lower over 1 year, which may signal that expectations and risk perceptions have shifted. Recent coverage has focused on Waystar Holding's position in healthcare services and...

In recent analyses, S&T Bancorp’s net interest income was found to have grown more slowly than the broader banking industry over the past five years and is now expected by sell-side analysts to decline by 5.3% in the coming 12 months, while earnings per share have fallen by 3.3% annually over the last two years on flat revenue. This combination of slowing core lending income and shrinking earnings, despite stable top-line performance, highlights ongoing pressure on the bank’s profitability...

Ryerson Holding (RYZ) has drawn investor attention after a period of weaker share performance, with the stock down over the past month and past 3 months despite its sizeable US metals processing footprint. See our latest analysis for Ryerson Holding. The 30 day share price return of 28.71% and 90 day return of 23.69% point to fading momentum. Meanwhile, the 1 year total shareholder return of 10.06% contrasts with a weaker 3 year total shareholder return of 37.54%, suggesting investors are...

Wondering if Alliant Energy’s current share price reflects its real worth, or if you might be paying too much for a regulated utility stock right now? The stock last closed at US$68.71, with a 7 day return of a 5.6% decline, a 30 day return of a 1.2% decline, a 1 year return of 12.5%, a 3 year return of 46.9%, and a 5 year return of 49.7%. These moves have come as investors continue to reassess regulated utilities as an income and stability option. Alliant Energy has attracted attention as...

Skyworks Solutions (NasdaqGS:SWKS) and Qorvo have agreed to merge, bringing together two long time rivals in radio frequency chip manufacturing. The companies plan to combine their product portfolios for mobile devices and connectivity solutions, subject to regulatory and shareholder approvals. The announcement reflects a move toward greater scale and broader customer coverage in key wireless and connectivity markets. For you as an investor, this merger brings two established radio...

Aveanna Healthcare Holdings (NasdaqGS:AVAH) announced the acquisition of Family First Homecare. The deal is intended to strengthen Aveanna's position in Florida and widen its geographic reach. The company also outlined a transformation that increased preferred payer agreements and set new M&A priorities for 2026. Aveanna Healthcare focuses on home based care services, an area many investors watch as care delivery shifts closer to the home. By adding Family First Homecare, the company is...

If you are wondering whether Enerpac Tool Group at around US$35.97 is a bargain, fairly priced, or looking stretched, this article walks through the key valuation angles to help you frame that question clearly. The stock is roughly flat over the last week with a 0.3% return. That sits against a 14.7% decline over the last month and a 14.8% decline over the last year, even as the 3 year and 5 year returns are 37.7% and 38.0% respectively. Recent coverage has focused on how Enerpac Tool Group...

Wondering if First Mid Bancshares at around US$39.44 is giving you fair value or a potential bargain? This article breaks down what the current price might be implying about the business. The stock is roughly flat over the last week at 0.1%, has seen a 9.2% decline over the past month, yet is still up 2.1% year to date and 15.5% over the last year, with a 59.7% return across three years and 0.4% over five years. Recent coverage around regional banks has focused on how share prices react to...

Wondering if Rezolve AI at US$2.53 is still priced for a turnaround or already baking in the story? This breakdown will help you frame what the current market price may be implying. The stock has been volatile recently, with a 5.9% decline over the last week, a 13.5% gain over the last month, an 11.8% year to date drop, and a 53.3% return over the past year, all set against a 74.9% decline over three years. Recent coverage has focused on Rezolve AI as an emerging player in the listed AI...

Starwood Real Estate Income Trust (OTCPK:SWDR) has posted its FY 2025 numbers with fourth quarter revenue of US$402.8 million, a basic EPS loss of US$0.39, and funds from operations of US$4.4 million in the red, setting the tone for a year where trailing twelve month revenue reached about US$1.6 billion alongside a net loss of US$691.6 million. Over recent quarters, revenue has moved in a tight band between US$389.7 million and US$420.2 million while EPS has remained in loss territory. As a...

IDT Corporation recently reported past second-quarter fiscal 2026 results showing higher sales and net income year-over-year, alongside improved earnings per share from continuing operations. The board also raised the annual dividend from US$0.24 to US$0.28 per share, signaling confidence in the company’s cash generation and capital return plans. With this dividend increase as a starting point, we’ll now examine how these developments could influence IDT’s broader investment narrative. AI is...

In March 2026, Walgreens announced a nationwide initiative with Exact Sciences and Workflow Services that lets eligible, average-risk customers request the FDA-approved, at-home Cologuard colorectal cancer screening test through its pharmacies, aiming to close care gaps with pharmacist-led services integrated into store workflows. At the same time, Exact Sciences highlighted new data on its Oncodetect molecular residual disease test and Cancerguard multi-cancer early detection assay at the...

Taysha Gene Therapies (NasdaqGS:TSHA) received FDA Breakthrough Therapy designation for TSHA-102 in Rett syndrome. The company reported a 100% patient response rate in pivotal Phase I/II data for TSHA-102. Regulators aligned with Taysha on pivotal trial designs for its lead Rett syndrome program. Taysha added a key commercial hire as it prepares for potential TSHA-102 commercialization. Taysha Gene Therapies, trading at $4.4 per share, has been drawing attention as its 1 year return stands...

Ambarella (NasdaqGS:AMBA) used a recent industry conference to outline a faster push into Edge AI products. The company highlighted a major shift in its revenue mix, new sales efforts aimed at smaller customers, and progress on a semi custom chip. Management also disclosed work on an upcoming two nanometer chip, signaling a move to more advanced manufacturing nodes. Ambarella, trading at about $54.02, has seen a mixed share price record, with a 3.3% gain over the past week but a 28.1%...